History

Sinclair Pharmaceuticals Limited was originally founded in 1971 by Andrew Sinclair to focus on the sale and marketing of pharmaceutical products in the UK.

From then, it has constantly consolidated its presence & turnover in the five leading European markets & developed its global reach through solid partnerships.

Sinclair Pharma keeps growing through company & product acquisitions, full-exploitation of in-house technologies & in/out-licensing partnerships.

1971	Creation of Sinclair Pharma Sale and marketing of pharmaceutical products in the UK
2000	Sinclair Pharma acquired by new management team Acquisition of Salix Pharma (Sweden) bringing SST for xerostomia
2001	Acquisition of ProPharma (Italy), bringing dermatology range including Atopiclair.
2002	Acquisition of Biosurface (Sweden), bringing Decapinol for gingivitis.
2003	IPO raised £8.9m
2005	Acquisition of Euroderm (Italy).
2006	Acquisition of CS Dermatologie, bringing dermatology range including Fazol, Tridésonit
2009	Company refinanced. New management team. Chris Spooner appointed as CEO Acquisition of Flammazine & Flammacerium Creation of Sinclair GmbH (Germany) Acquisition of Sinclair Pharmaceutical España (Spain)
2010	Rights to licence Kelo-Cote acquired for France, Italy and Spain Atopiclair cream reimbursed in France
2011	Merger with IS Pharma

Member space

Subscribe
Forgot Password

Email

Password
Latest news

01/13/2012 07:00

Trading update Trading update

12/08/2011 07:00

Acquisition of Advanced Bio-Technologies Inc. Acquisition of Advanced Bio-Technologies Inc.

11/15/2011 07:00

Disposal of Mysoline Disposal of Mysoline
SPH Share price

This frame displays Sinclair Pharma's share price, if you can't view this feed please access the price directly at <a href="http://qq.axl.co.uk/axl-dlls/publish?url=/templates/ir/sinclairpharma/tinyprice.html">http://qq.axl.co.uk/axl-dlls/publish?url=/templates/ir/sinclairpharma/tinyprice.html</a>
Charity

On 15^th May 2011 Sinclair Pharma’s employees united to take part in ‘Walk the Wight’, the annual fundraising event organised by and in aid of the Earl Mountbatten Hospice on the Isle of Wight.

Sinclair Pharma’s team was comprised of 42 employees from Sinclair’s affiliates in France, Italy, Spain and the UK, who had donated their weekend to participate in the walk which began in Bembridge and ended in Carisbrooke, covering a total distance of 20 km. The walking time amassed to six hours and 15 minutes, during which the team tackled the undulating paths of the island’s terrain, battling the discomfort of blisters and aching limbs. In order to enhance the challenge, the team of walkers also camped out in tents on the eve of the event, managing with tremendous spirit to both construct and dismantle the tents before and after use.

While Sinclair’s employees have long been supporters of various charitable causes, this year’s ‘Walk the Wight’ marks the first time that members from all affiliates were invited to join together to engage in a common fundraising activity – an initiative that will soon be repeated as Sinclair develops its charity programme. We are delighted to confirm that Sinclair has raised a total sum of £10,088 for the event’s organiser and charity, the Earl Mountbatten Hospice.

The weekend was a great team building experience for all involved and thanks are owed to both the participants and sponsors, whose respective contributions rendered the event a terrific success.

Short films

Message from Chief Executive Officer and Chief Operating Officer

Message from Chief Executive Officer and Group Technical Director

Sinclair IS Pharma in the UK

Sinclair IS Pharma in Germany, Austria and Switzerland

Sinclair IS Pharma in Asia

Sinclair IS Pharma in Americas

History

Trading update Trading update

Acquisition of Advanced Bio-Technologies Inc. Acquisition of Advanced Bio-Technologies Inc.

Disposal of Mysoline Disposal of Mysoline

Short films